| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP317525 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 3 from ORIGENE TECHNOLOGIES | TP312672 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 4 from ORIGENE TECHNOLOGIES | TP312719 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR560904 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR560985 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR560994 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561002 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561018 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561031 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561050 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561085 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561149 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561189 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561190 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561261 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561262 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561270 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561303 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561304 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561371 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561386 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561387 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561396 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561400 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561427 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561472 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561557 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561599 | 5 ug | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS812044 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS514879 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS516244 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS516245 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS525107 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS557973 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS600150 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS600151 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS609733 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS623221 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS636640 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS710627 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS716738 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS716739 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS716814 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS802495 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS813605 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS503129 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS503922 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS507727 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS507730 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast, atypical from ORIGENE TECHNOLOGIES | CS515332 | 5x5um | ORIGENE TECHNOLOGIES |